Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela A Bota

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|December 14, 2022
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessmentDaniela A Bota, Thomas H Taylor, David E Piccioni, et al.
International Journal of Molecular Sciences|August 29, 2018
Therapeutic Immunization against GlioblastomaVirgil E J C Schijns, Chrystel Pretto, Anna M Strik, et al.
Journal of Neurosurgery|March 5, 2013
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical articleMarlon G Saria, Courtney Corle, Jethro Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II TrialDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.
JAMA Network Open|July 17, 2025
A Digital Asthma Self-Management Program for Adults: A Randomized Clinical TrialJordan Silberman, Siavash Sarlati, Bronwyn Harris, et al.
JCO Precision Oncology|February 6, 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1HMohamed A Gouda, Zihan Wei, Jordi Rodon, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Cell Reports|June 26, 2022
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteinsEvan A Elko, Georgia A Nelson, Heather L Mead, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|December 14, 2022
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessmentDaniela A Bota, Thomas H Taylor, David E Piccioni, et al.
International Journal of Molecular Sciences|August 29, 2018
Therapeutic Immunization against GlioblastomaVirgil E J C Schijns, Chrystel Pretto, Anna M Strik, et al.
Journal of Neurosurgery|March 5, 2013
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical articleMarlon G Saria, Courtney Corle, Jethro Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II TrialDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.
JAMA Network Open|July 17, 2025
A Digital Asthma Self-Management Program for Adults: A Randomized Clinical TrialJordan Silberman, Siavash Sarlati, Bronwyn Harris, et al.
JCO Precision Oncology|February 6, 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1HMohamed A Gouda, Zihan Wei, Jordi Rodon, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Cell Reports|June 26, 2022
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteinsEvan A Elko, Georgia A Nelson, Heather L Mead, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Pageof 9